Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Pediatr Blood Cancer ; 70(4): e30174, 2023 04.
Article in English | MEDLINE | ID: covidwho-2273917

ABSTRACT

Personalized, risk-stratified care aims to "right size" the involvement of primary care providers (PCPs), oncology and specialized practitioners in caring for cancer survivors. Our survey found limited comfort among PCPs in cancer surveillance and management of treatment-related effects. In hypothetical case scenarios, PCPs reported least comfort in caring for a survivor of childhood cancer, followed by young adult-onset cancer, and greater comfort in caring for a survivor of adult-onset breast cancer. While education and training of PCPs is essential, risk-stratification strategies need to identify patients who may transition to primary care and those who may require ongoing survivorship-focused follow-up.


Subject(s)
Breast Neoplasms , Cancer Survivors , Neoplasms , Young Adult , Humans , Female , Survivors , Medical Oncology , Primary Health Care
3.
Transl Behav Med ; 11(11): 1989-1997, 2021 11 30.
Article in English | MEDLINE | ID: covidwho-1546028

ABSTRACT

In this commentary, we discuss opportunities to optimize cancer care delivery in the next decade building from evidence and advancements in the conceptualization and implementation of multi-level translational behavioral interventions. We summarize critical issues and discoveries describing new directions for translational behavioral research in the coming decade based on the promise of the accelerated application of this evidence within learning health systems. To illustrate these advances, we discuss cancer prevention, risk reduction (particularly precision prevention and early detection), and cancer treatment and survivorship (particularly risk- and need-stratified comprehensive care) and propose opportunities to equitably improve outcomes while addressing clinician shortages and cross-system coordination. We also discuss the impacts of COVID-19 and potential advances of scientific knowledge in the context of existing evidence, the need for adaptation, and potential areas of innovation to meet the needs of converging crises (e.g., fragmented care, workforce shortages, ongoing pandemic) in cancer health care delivery. Finally, we discuss new areas for exploration by applying key lessons gleaned from implementation efforts guided by advances in behavioral health.


Subject(s)
COVID-19 , Neoplasms , Delivery of Health Care , Health Services Research , Humans , Neoplasms/prevention & control , Risk Reduction Behavior , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL